Jiawei Shengjiangsan's Effect on Renal Injury in Diabetic Nephropathy Mice is Investigated via the PI3K/Akt/NF-κB Signaling Pathway
Chenhua Yang,Fengling Huang,Huiqin Fang,Yunhua Zang
DOI: https://doi.org/10.2147/dmso.s456205
2024-04-12
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Chenhua Yang, 1 Fengling Huang, 2 Huiqin Fang, 3 Yunhua Zang 1 1 General Medicine, Bao'an Authentic TCM Therapy Hospital, Shenzhen, Guangdong, People's Republic of China; 2 College of Traditional Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China; 3 The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China Correspondence: Yunhua Zang, Bao'an Authentic TCM Therapy Hospital, No. 99, Lai'an Road, Xixiang Street, Bao'an District, Shenzhen, Guangdong, 518101, People's Republic of China, Email Purpose: This study aimed to investigate the intervention mechanism of Jiawei Shengjiangsan (JWSJS) on kidney injury in diabetic nephropathy mice. Methods: Thirty 8-week-old db/db mice were randomly divided into five groups: model group, Perindopril group, and JWSJS low-, medium-, and high-dose groups (n=6 per group) based on body weight. Additionally, a blank control group was established consisting of 6 db/m mice aged 8 weeks. The blank and model groups received daily intragastric administration of 7g/kg/d pure water. The remaining groups were assigned to JWSJS low (3.5g/kg/d), medium (7g/kg/d), high (14g/kg/d) dosage groups, and perindopril positive control group (0.48mg/kg/d) for 12 weeks. Post-experiment, serum creatinine (SCr) and blood urea nitrogen (BUN) were analyzed using an automatic biochemical analyzer. Enzyme-linked immunosorbent assay (ELISA) measured 24-hour urinary albumin, neutrophil gelatinase-associated lipocalin (NGAL), TNF-α, IL-1β, VCAM-1, MCP-1, and HbA1c. Western blot assessed the protein expressions of p-PI3K, p-Akt, and p-NF-κB p65, while pathological kidney changes were observed. Results: Compared to the blank group, the model group exhibited increased SCr, BUN, 24-hour urinary albumin, serum NGAL, TNF-α, IL-1β, VCAM-1, MCP-1, HbA1c, p-PI3K, and p-Akt, alongside increased p-NF-κB p65 expression, indicating significant kidney pathology. After treatment, the JWSJS group showed decreased SCr, BUN, 24-hour urinary microalbumin, NGAL, HbA1c, TNF-α, IL-1β, VCAM-1, MCP-1 levels, increased p-PI3K and p-Akt expression (P< 0.05), and reduced p-NF-κB p65 content (P< 0.05). Histopathological analysis revealed that JWSJS ameliorated renal tubular epithelial cell damage, glomerular capillary and basement membrane injuries, and facilitated the repair of damaged podocytes in diabetic nephropathy mice. Conclusion: JWSJS demonstrated efficacy in reducing renal inflammation in diabetic nephropathy mice, with its mechanism likely associated with the inhibition of the PI3K/Akt/NF-κB signaling pathway. Keywords: Jiawei Shengjiangsan, diabetic nephropathy, PI3K/Akt/NF-κB signaling pathway, db/db mice, inflammation Diabetic nephropathy (DN) stands out as a prominent microvascular complication of diabetes mellitus and represents the primary cause of end-stage renal disease. Recent years have witnessed a surge in the incidence of DN. 1,2 This disease manifests progressively, with initial clinical stages marked by proteinuria and glomerular hyperfiltration. As the condition progresses, there is a gradual decline in the glomerular filtration rate. 3 Studies have shown that diabetes-induced proteinuria primarily exhibits disruption of the fissure diaphragm's integrity, loss of podocytes, and thickening of the glomerular basement membrane. 4 Podocytes, being highly differentiated cells forming the glomerular filtration barrier alongside vascular endothelial cells and the basement membrane, 5 play a crucial role. Impairment of this barrier has been linked to proteinuria, glomerular lesions, and renal function abnormalities. 6,7 Due to the limited regenerative capacity of podocytes, their injury and loss contribute to the destruction of the glomerular filtration membrane, exacerbating the nephropathic process. 8,9 Given the side effects associated with podocyte-protective drugs like angiotensin-converting enzyme inhibitors (ACEI) and endothelin receptor antagonists, such as hyperkalemia, exploring new and safe drugs for DN treatment is imperative. 10 Therefore, naturally produced drugs like traditional Chinese medicine (TCM) have attracted significant interest in recent years. Jiawei Shengjiangsan, an empirical formula for DN treatment in TCM, has a historical track record, yet its impact on DN and the underlying mechanisms remain unclear, warranting further research. The etiology of DN is complex and diverse, with inflammatory mechanisms being a major known pathogenic factor. 11 It has been reported that the downstream signaling pathway of Phosphatidylinositol 3-ki -Abstract Truncated-
endocrinology & metabolism